000 | 01502 a2200457 4500 | ||
---|---|---|---|
005 | 20250511135309.0 | ||
264 | 0 | _c19800215 | |
008 | 198002s 0 0 eng d | ||
022 | _a0301-0430 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMcKenzie, P E | |
245 | 0 | 0 |
_aPlasmapheresis in glomerulonephritis. _h[electronic resource] |
260 |
_bClinical nephrology _cSep 1979 |
||
300 |
_a97-108 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAgammaglobulinemia _xetiology |
650 | 0 | 4 |
_aAnti-Glomerular Basement Membrane Disease _xtherapy |
650 | 0 | 4 |
_aComplement System Proteins _xanalysis |
650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
650 | 0 | 4 |
_aDipyridamole _xadministration & dosage |
650 | 0 | 4 |
_aEndocarditis, Bacterial _xcomplications |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlomerulonephritis _xtherapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIgA Vasculitis _xcomplications |
650 | 0 | 4 |
_aImmunoglobulins _xanalysis |
650 | 0 | 4 |
_aLiver Cirrhosis _xcomplications |
650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xcomplications |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPlasmapheresis _xadverse effects |
650 | 0 | 4 |
_aPrednisolone _xadministration & dosage |
700 | 1 | _aTaylor, A E | |
700 | 1 | _aWoodroffe, A J | |
700 | 1 | _aSeymour, A E | |
700 | 1 | _aChan, Y L | |
700 | 1 | _aClarkson, A R | |
773 | 0 |
_tClinical nephrology _gvol. 12 _gno. 3 _gp. 97-108 |
|
999 |
_c530211 _d530211 |